Maternal RSV


Sundance Clinical Research is participating in a study evaluating an investigational vaccine given to
healthy pregnant women to see if it may protect their babies against Respiratory
Syncytial Virus, or RSV for short. 

Eligible participants…

  • Are 18 to 49 years of age

  • Are a healthy pregnant woman expecting a healthy baby

  • Will be between 24 and 36 weeks pregnant on the day of your study injection

  • Meet additional requirements as determined by a screening process

 >> Check here to see if you qualify! 

For more information, submit your information using the link below. After you submit your information, a specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

Click here to learn more about this study.

You can also talk to a Sundance Patient Recruitment Specialist about this study by calling (314) 567-3377.